Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 77 citing articles:

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Eric A. Meyerowitz, Aaron Richterman
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 267-293
Open Access | Times Cited: 17
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort Study
J. Daniel Kelly, Scott Lu, Khamal Anglin, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_2, pp. S193-S204
Open Access | Times Cited: 16
Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study
Roderick P Venekamp, Irene Veldhuijzen, Karel G.M. Moons, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries
Janneke D. M. Verberk, Marieke L. A. de Hoog, Ilse Westerhof, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 5, pp. 549-561
Open Access | Times Cited: 15
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis
Zachary J. Madewell, Yang Yang, Ira M. Longini, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands
Brechje de Gier, Stijn P. Andeweg, Jantien A. Backer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others?
Günter Kampf
Advances in experimental medicine and biology (2024), pp. 247-264
Closed Access | Times Cited: 2
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo
E. Gary, Nicholas J. Tursi, Bryce M. Warner, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100693-100693
Open Access | Times Cited: 11
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study
Anne J. Huiberts, Brechje de Gier, Christina E. Hoeve, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
Samuel Clifford, Pauline Waight, Jada Hackman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals
Stijn P. Andeweg, Harry Vennema, Irene Veldhuijzen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 14
The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China
Yuxue Liao, Jiao Su, Jieru Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2
Marlena S. Bannick, Fei Gao, Elizabeth R. Brown, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 6, pp. 1016-1028
Open Access | Times Cited: 4
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
Senna C.J.L. van Iersel, Scott McDonald, Brechje de Gier, et al.
Vaccine (2023) Vol. 41, Iss. 26, pp. 3847-3854
Open Access | Times Cited: 4
Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021–2022
Iván Martínez‐Baz, Camino Trobajo‐Sanmartín, Ana Miqueleiz, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 58-58
Open Access | Times Cited: 1
Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China
Xiao‐Feng He, Yuxue Liao, Yuanhao Liang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Effectiveness of 4th doses of bivalent mRNA vaccine in reinfections from October 2022 to October 2023 in a general medicine office in Toledo (Spain)
José Luis Turabián
Archives of Community Medicine and Public Health (2024) Vol. 10, Iss. 1, pp. 001-006
Open Access | Times Cited: 1
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China
Zihao Guo, Ting Zeng, Yaoqin Lu, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Observational study on the characteristics of COVID-19 transmission dynamics during the first wave of the epidemic in Lusaka, Zambia
Millica Phiri, Tadatsugu Imamura, Patrick Sakubita, et al.
Pan African Medical Journal (2024) Vol. 48
Open Access | Times Cited: 1
Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers
Jong Hoon Hyun, Yongjung Park, Young Goo Song, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 12, pp. 1078-1078
Open Access | Times Cited: 6
Predictors of discharge disposition and mortality following hospitalization with SARS-CoV-2 infection
Farha Ikramuddin, Tanya Melnik, Nicholas E. Ingraham, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0283326-e0283326
Open Access | Times Cited: 3
Networks of necessity: Simulating COVID-19 mitigation strategies for disabled people and their caregivers
Thomas E. Valles, Hannah Shoenhard, Joseph Zinski, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 5, pp. e1010042-e1010042
Open Access | Times Cited: 5
Over- and under-estimation of vaccine effectiveness
Hilla De-Leon, Dvir Aran
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations
Chirag K. Kumar, Ruchita Balasubramanian, Stefano Ongarello, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271103-e0271103
Open Access | Times Cited: 5
Relative COVID-19 Vaccine Booster Effectiveness and Clinical- Epidemiological Characteristics Before and After 29 Days of Shot
José Luis Turabián, J. Omari Johnson
Archives of Pharmacology and Therapeutics (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 5

Scroll to top